1. Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model
- Author
-
Young-ho Jung, Young Ah Ku, Jayoon Moon, Seunghoon Kim, Jin Suk Ryu, Chang Ho Yoon, Myung Hee Chung, Yong Ho Kim, Mee Kum Kim, and Dong Hyun Kim
- Subjects
RCI001 ,Dry eye disease ,Inflammation ,Oxidative stress ,Therapeutics ,Ophthalmology ,RE1-994 - Abstract
Abstract Background To evaluate the therapeutic effects of topical RCI001 (RCI) and compare its efficacy with that of 1% prednisolone acetate (PDE) and 5% Lifitegrast in a modified mixed dry eye disease (DED) model. Methods The environmental DED model was induced in BALB/c mice in a dry chamber with scopolamine. The eyes of the mice were treated topically with phosphate buffered saline (PBS), PDE, Lifitegrast or RCI twice daily for 1 week. Ocular surface staining (OSS), tear secretion, inflammatory cytokines in the ocular surface and lacrimal gland, and immunofluorescence staining in the conjunctiva and cornea(CC) were assessed. Results The RCI group demonstrated better improvement of OSS and tear secretion than the PBS group (OSS, PBS: 13.0 ± 1.6, RCI: 9.4 ± 3.0; tear secretion, PBS: 5.0 ± 0.4 mm, RCI: 7.0 ± 0.3 mm, each P
- Published
- 2024
- Full Text
- View/download PDF